Doctor charged with overprescribing painkillers
Dr. Segun Rasaki, 49, prescribed drugs like hydrocodone and methadone to people who didn’t need them, and submitted fraudulent insurance claims such as duplicate billings, according to court documents.
Dr. Segun Rasaki, 49, prescribed drugs like hydrocodone and methadone to people who didn’t need them, and submitted fraudulent insurance claims such as duplicate billings, according to court documents.
How would a single-payer national health insurance program change the finances for employers, workers, doctors and hospitals?
The community college is cutting hours for part-time professors in response to the health care reform law, which requires employers to provide coverage to part-time employees who work 30 hours a week or more.
Public broadcasting station WFYI-FM 90.1 aims to expand distribution of its locally produced “Sound Medicine” show to include at least 30 radio stations in large- and medium-sized markets in the next two years.
In this age of austerity, there’s almost no chance of Indianapolis hospitals creating a Cleveland Clinic-like hub of innovation.
If approved, the drug would be a potent boost to Lilly’s product portfolio. It would also mean a critical new therapy for a cancer that’s proven difficult to treat.
Symbios Medical Products LLC filed for Chapter 7 bankruptcy liquidation, costing numerous Indianapolis-area angel investors large sums.
Starting with this post, I’m going to periodically give you a peek at my reading list. I’ll highlight reports and reportage that I have found either helpful or provocative. I hope you do, too.
The local orthopedic surgeons are presenting themselves as low-cost providers in an attempt to reverse growth restrictions imposed by Obamacare.
Indiana-based Zimmer Holdings Inc., which lost a February trial against Stryker Corp. over a surgical device patent, was told to pay three times the jury award, plus other costs.
By and large, Obamacare will leave in place the same major problems in the health care systems that existed before the law was passed—in both Indiana and across the nation.
Bloomington-based Cook Medical Inc. recently launched two new products and expects to launch eight to 10 more over the next year.
Michael Evans was juggling two companies and two newborn twins when his board of directors suggested it was time for a new CEO of AIT Laboratories. He was replaced by venture capitalist Matt Neff on Monday.
Roche’s diabetes care unit, which employs more than 900 in Indianapolis, suffered a 14-percent decline in revenue during the first half of 2013. Roche has reportedly put the unit up for sale.
Obamacare is destined to fail for one key reason: it will make health insurance cost more and buy less.
It’s the latest in a string of leadership changes at the testing lab. Neff is coming from CHV Capital, the venture capital arm of Indiana University Health, where he had been CEO.
Venture capital surged in the first half of 2012, to $51.6 million in Indiana. But the pace of activity here fell off sharply in the second half of last year, and remained sluggish into 2013.
The Carmel-based financial services company said that, during the second quarter, it repurchased $59.4 million of its securities, including 4.4 million common shares for $50 million.
This is the first of three blog posts, each of which will make a compelling case for one of three distinct positions on Obamacare in Indiana: why it will succeed, why it will fail and why it will be a “non-event.”
Lawyers for the state and Planned Parenthood of Indiana and Kentucky filed a proposed final judgment in the case Monday in federal court in Indianapolis.